|
CEP57 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.853800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.530600E-01 |
| Normal-vs-Stage2 |
5.484000E-01 |
| Normal-vs-Stage3 |
1.037170E-01 |
| Normal-vs-Stage4 |
1.459640E-01 |
| Stage1-vs-Stage2 |
9.200800E-01 |
| Stage1-vs-Stage3 |
5.397300E-03 |
| Stage1-vs-Stage4 |
1.253570E-02 |
| Stage2-vs-Stage3 |
1.358570E-01 |
| Stage2-vs-Stage4 |
1.290820E-01 |
| Stage3-vs-Stage4 |
9.110000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.920400E-01 |
| Normal-vs-AfricanAmerican |
9.820800E-03 |
| Normal-vs-Asian |
6.437400E-01 |
| Caucasian-vs-AfricanAmerican |
7.100400E-03 |
| Caucasian-vs-Asian |
8.846000E-01 |
| AfricanAmerican-vs-Asian |
1.801780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.237000E-01 |
| Normal-vs-Female |
9.091200E-01 |
| Male-vs-Female |
8.396600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.491600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.388400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.948200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.097600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.411400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.498200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.276600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.896200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.436800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.391800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.631620E-01 |
| Normal-vs-Grade 2 |
2.741700E-02 |
| Normal-vs-Grade 3 |
1.700250E-01 |
| Normal-vs-Grade 4 |
2.839600E-02 |
| Grade 1-vs-Grade 2 |
5.925200E-01 |
| Grade 1-vs-Grade 3 |
3.778400E-02 |
| Grade 1-vs-Grade 4 |
4.030500E-02 |
| Grade 2-vs-Grade 3 |
4.402800E-04 |
| Grade 2-vs-Grade 4 |
2.563600E-04 |
| Grade 3-vs-Grade 4 |
1.466030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.430700E-04 |
| Normal-vs-ccB subtype |
1.162170E-01 |
| ccA subtype-vs-ccB subtype |
2.53019999996162E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.959000E-01 |
| Normal-vs-N1 |
5.642100E-03 |
| N0-vs-N1 |
5.760200E-02 |
|
|
